Foghorn Therapeutics Inc. Operating Lease Liability
Foghorn Therapeutics Inc. (FHTX) had Operating Lease Liability of $43.10 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability $43.10M.
- 2026-03-31: Operating Lease, Liability $41.99M.
- 2025-12-31: Operating Lease, Liability $41.27M.
- 2025-09-30: Operating Lease, Liability $22.53M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $43.10M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $41.99M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $41.27M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $22.53M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $23.70M 10-Q · filed 2025-08-05 |
| 2024-12-31 | $37.13M 10-K · filed 2026-03-11 |
| 2023-12-31 | $45.07M 10-K · filed 2025-03-06 |
| 2022-12-31 | $51.51M 10-K · filed 2024-03-07 |
| 2021-12-31 | $58.33M 10-K · filed 2023-03-09 |
| 2021-09-30 | $60.01M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $61.64M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $62.33M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $62.34M 10-K/A · filed 2022-08-09 |
| 2020-09-30 | $56.10M 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |